NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Honestly, it is quite obvious why. It is a trial with enough anomalous circumstances, though not affecting the validity of the results in truth, but enough to allow bad actors to make a mess of things if it is purely a commercial presentation of the results. Announcing TLD is nothing more than a commercial company saying what they believe and shorts KNOW this to be true and seem almost outraged that a journal article will undermine what was always obviously the strategy. They will no doubt still try, but a journal article versus whatever they throw at it, will be imperative their grenades. Their critiques will seem either competitive bad blood or commercial bad acts, even if hidden behind a “scientist”.

That is the reality.

Meanwhile, the DOJ has opened a serious investigation and I doubt this situation would be immaterial.